| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Feb 21, 2024 | Sale | $7.46 | 3,764 | 28,079 | 175,669 | Feb 22, 2024, 04:32 PM | |
| VYGR | Voyager Therapeutics, Inc. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Oct 03, 2023 | Sale | $6.99 | 13,567 | 94,833 | 149,433 | Oct 05, 2023, 04:41 PM | |
| FREQ | Frequency Therapeutics, Inc. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Feb 22, 2022 | Sale | $3.53 | 1,542 | 5,442 | 8,927 | Feb 23, 2022, 04:38 PM | |
| FREQ | Frequency Therapeutics, Inc. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Feb 18, 2022 | Sale | $3.88 | 1,404 | 5,443 | 10,469 | Feb 23, 2022, 04:38 PM | |
| FREQ | Frequency Therapeutics, Inc. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Feb 16, 2022 | Sale | $4.43 | 1,229 | 5,443 | 13,169 | Feb 18, 2022, 04:14 PM | |
| FREQ | Frequency Therapeutics, Inc. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Feb 17, 2022 | Sale | $4.20 | 1,296 | 5,443 | 11,873 | Feb 18, 2022, 04:14 PM | |
| URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Oct 15, 2020 | Sale | $21.77 | 2,400 | 52,248 | 11,829 | Oct 16, 2020, 03:41 PM | |
| URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Sep 01, 2020 | Sale | $22.82 | 509 | 11,615 | 7,888 | Sep 01, 2020, 02:37 PM | |
| URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Jul 27, 2020 | Sale | $23.51 | 141 | 3,315 | 7,355 | Jul 28, 2020, 05:34 PM | |
| URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Officer | May 20, 2020 | Sale | $25.07 | 358 | 8,975 | 7,079 | May 20, 2020, 04:44 PM | |
| URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Apr 27, 2020 | Sale | $24.35 | 141 | 3,433 | 6,396 | Apr 28, 2020, 01:51 PM | |
| URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Feb 20, 2020 | Sale | $29.68 | 360 | 10,685 | 6,120 | Feb 24, 2020, 04:53 PM | |
| URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Jan 27, 2020 | Sale | $29.28 | 667 | 19,530 | 4,438 | Jan 28, 2020, 05:15 PM | |
| URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Nov 20, 2019 | Sale | $28.41 | 354 | 10,057 | 3,439 | Nov 22, 2019, 01:29 PM | |
| URGN | UroGen Pharma Ltd. | PFREUNDSCHUH PETER P. | Chief Financial Officer | Aug 20, 2019 | Sale | $33.07 | 1,416 | 46,827 | 2,751 | Aug 22, 2019, 01:31 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | PFREUNDSCHUH PETER P. | CFO | Feb 13, 2018 | Option Exercise | $18.00 | 263 | 4,734 | 0 | Feb 13, 2018, 04:47 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | PFREUNDSCHUH PETER P. | CFO | Sep 30, 2017 | Option Exercise | $9.10 | 131 | 1,192 | 131 | Jan 12, 2018, 06:05 PM | |
| SCMP | Sucampo Pharmaceuticals, Inc. | PFREUNDSCHUH PETER P. | CFO | Dec 31, 2017 | Option Exercise | $9.10 | 263 | 2,393 | 263 | Jan 12, 2018, 06:05 PM |
Menu